VENROCK ASSOCIATES IV L P Insider Trading $BLPH Bellerophon Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for VENROCK ASSOCIATES IV L P.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of VENROCK ASSOCIATES IV L P. VENROCK ASSOCIATES IV L P is 10% Owner in ALIMERA SCIENCES INC ($ALIM) and 10% Owner in Achaogen Inc ($AKAO) and 10% Owner in QUANTENNA COMMUNICATIONS INC ($QTNA) and 10% Owner in Anacor Pharmaceuticals, Inc. ($ANAC) and 10% Owner in Bellerophon Therapeutics, Inc. ($BLPH).

VENROCK ASSOCIATES IV L P in Bellerophon Therapeutics, Inc.

Trading Symbol: BLPH
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of VENROCK ASSOCIATES IV L P: 10% Owner
Holdings: 6,824,425 shares
Current Value: $4,504,121
Latest Transaction: Oct 28 2019
$BLPH Market Capitalization: $9.84M
$BLPH Previous Close: $0.66

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of VENROCK ASSOCIATES IV L P in Bellerophon Therapeutics, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, AKAO, ALIM, ANAC, BLPH, QTNA

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Oct 28 2019	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Sell	S	0.44	333,010	146,091	6,435,173	6.8 M to 6.4 M (-4.92 %)
Oct 28 2019	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Sell	S	0.45	56,242	25,511	6,768,183	6.8 M to 6.8 M (-0.82 %)
Oct 28 2019	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Sell	S	0.50	704,595	353,354	6,824,425	7.5 M to 6.8 M (-9.36 %)
Oct 28 2019	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Sell	S	0.44	333,010	146,091	6,435,173	6.8 M to 6.4 M (-4.92 %)
Oct 28 2019	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Sell	S	0.45	56,242	25,511	6,768,183	6.8 M to 6.8 M (-0.82 %)
Oct 28 2019	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Sell	S	0.50	704,595	353,354	6,824,425	7.5 M to 6.8 M (-9.36 %)
Mar 14 2019	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.70	142,857	100,000	7,529,020	7.4 M to 7.5 M (+1.93 %)
Mar 14 2019	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.70	142,857	100,000	7,529,020	7.4 M to 7.5 M (+1.93 %)
Sep 17 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.18	60,000	70,944	7,386,163	7.3 M to 7.4 M (+0.82 %)
Sep 17 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.23	75,000	92,250	7,326,163	7.3 M to 7.3 M (+1.03 %)
Sep 17 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.19	75,000	89,160	7,251,163	7.2 M to 7.3 M (+1.05 %)
Sep 17 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.18	60,000	70,944	7,386,163	7.3 M to 7.4 M (+0.82 %)
Sep 17 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.23	75,000	92,250	7,326,163	7.3 M to 7.3 M (+1.03 %)
Sep 17 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.19	75,000	89,160	7,251,163	7.2 M to 7.3 M (+1.05 %)
Sep 12 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.15	75,000	85,913	7,176,163	7.1 M to 7.2 M (+1.06 %)
Sep 12 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.14	200,000	228,840	7,101,163	6.9 M to 7.1 M (+2.90 %)
Sep 12 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.22	200,000	243,640	6,901,163	6.7 M to 6.9 M (+2.98 %)
Sep 12 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.15	75,000	85,913	7,176,163	7.1 M to 7.2 M (+1.06 %)
Sep 12 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.14	200,000	228,840	7,101,163	6.9 M to 7.1 M (+2.90 %)
Sep 12 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	1.22	200,000	243,640	6,901,163	6.7 M to 6.9 M (+2.98 %)
Sep 07 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.90	60,000	53,742	6,701,163	6.6 M to 6.7 M (+0.90 %)
Sep 07 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.84	50,000	42,095	6,641,163	6.6 M to 6.6 M (+0.76 %)
Sep 07 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.85	50,000	42,325	6,591,163	6.5 M to 6.6 M (+0.76 %)
Sep 07 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.90	60,000	53,742	6,701,163	6.6 M to 6.7 M (+0.90 %)
Sep 07 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.84	50,000	42,095	6,641,163	6.6 M to 6.6 M (+0.76 %)
Sep 07 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.85	50,000	42,325	6,591,163	6.5 M to 6.6 M (+0.76 %)
Aug 16 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.65	66,393	43,109	6,541,163	6.5 M to 6.5 M (+1.03 %)
Aug 16 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.65	272,000	175,902	6,474,770	6.2 M to 6.5 M (+4.39 %)
Aug 16 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.65	190,977	123,868	6,202,770	6 M to 6.2 M (+3.18 %)
Aug 16 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.65	66,393	43,109	6,541,163	6.5 M to 6.5 M (+1.03 %)
Aug 16 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.65	272,000	175,902	6,474,770	6.2 M to 6.5 M (+4.39 %)
Aug 16 2018	BLPH	Bellerophon Therap ...	VENROCK ASSOCIATES IV L P	10% Owner	Buy	P	0.65	190,977	123,868	6,202,770	6 M to 6.2 M (+3.18 %)

Page: 1